nicotinum 39.37 mg, triglycerida media, copolymerum methacrylatis butylati basicum, 2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in ethylacetate/heptane (85:15), kalii hydroxidum, carmellosum natricum conexum, aluminii acetylacetonas pro praeparatione, cum liberatione 25 mg/16h.
Packungsbestandteile
Transdermal System
Active Agent
Dose
Nicotine
39.37 mg
Inactive agents
2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in Ethylacetate/heptane (85:15)
Aluminii Acetylacetonas
Carmellosum Natricum Conexum
Copolymerum Methacrylatis Butylati Basicum
Kalii Hydroxidum
Triglycerida Media
Source
Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
